|
| 34779303 | Telephone versus in-person genetic counseling for hereditary cancer risk: Patient predictors of differential outcomes. | J Telemed Telecare | 2024 |
| 37794678 | Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility. | HGG Adv | 2024 |
| 36222934 | ASO Visual Abstract: Screening MRI Does Not Increase Cancer Detection or Result in Earlier Stage at Diagnosis in Patients with High-Risk Breast Lesions-A Propensity Score Analysis. | Ann Surg Oncol | 2023 |
| 37707803 | Right-Sizing Models of Genetic Cancer Predisposition Testing. | JAMA Oncol | 2023 |
| 38061009 | Endometrial Cancer Risk Among Germline <i>BRCA1</i>/<i>2</i> Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps. | JCO Precis Oncol | 2023 |
| 37992259 | Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic <i>BRCA1</i>/<i>2</i>, Germline <i>PALB2</i>, or Homologous Recombination Deficiency Signature. | JCO Precis Oncol | 2023 |
| 37579253 | Germline <i>EGFR</i> Mutations and Familial Lung Cancer. | J Clin Oncol | 2023 |
| 37733980 | Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial. | JCO Oncol Pract | 2023 |
| 37259799 | Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ. | Cancer Prev Res (Phila) | 2023 |
| 37291133 | Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles. | Nat Commun | 2023 |
| 37218034 | Intraindividual phenotyping of depression in high-risk youth: An application of a multilevel hidden Markov model. | Dev Psychopathol | 2023 |
| 37214493 | Results of a randomized controlled trial of a decision support intervention for disclosing maternal <i>BRCA</i> genetic test results to children and adolescents. | PEC Innov | 2023 |
| 37210568 | Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies. | Oncologist | 2023 |
| 37178433 | Correction to: Pathogenic variants among females with breast cancer and a nonâ¿¿breast cancer reveal opportunities for cancer interception. | Breast Cancer Res Treat | 2023 |
| 37471023 | Relations among symptoms of depression over time in at-risk youth. | J Psychopathol Clin Sci | 2023 |
| 37358525 | Racial/ethnic differences in parenting behaviors among depressed parents. | J Fam Psychol | 2023 |
| 36856935 | Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. | Breast Cancer Res Treat | 2023 |
| 36245263 | Summary of the experiences, knowledge, medical management, and family communication of monoallelic MUTYH carriers. | J Genet Couns | 2023 |
| 36171529 | Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis. | Ann Surg Oncol | 2023 |
| 36126817 | Twenty-year Outcomes of a Pediatric Chronic Abdominal Pain Cohort: Early Adulthood Health Status and Offspring Physical and Behavioral Health. | J Pain | 2023 |
| 34173196 | Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR Study. | J Gen Intern Med | 2022 |
| 35774415 | An optimized protocol for evaluating pathogenicity of <i>VHL</i> germline variants in patients suspected with von Hippel-Lindau syndrome: Using somatic genome to inform the role of germline variants. | MethodsX | 2022 |
| 35654360 | Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 Status. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35617956 | A human breast atlas integrating single-cell proteomics and transcriptomics. | Dev Cell | 2022 |
| 35772246 | Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D. | Breast | 2022 |
| 35549571 | The Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33): A User's Guide. | J Clin Child Adolesc Psychol | 2022 |
| 35378642 | Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen. | Breast Cancer Res Treat | 2022 |
| 35396508 | PARP inhibition in breast cancer: progress made and future hopes. | NPJ Breast Cancer | 2022 |
| 35363308 | Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program. | Clin Cancer Res | 2022 |
| 35816916 | Effects of personalized depression prevention on anxiety through 18-month follow-up: A randomized controlled trial. | Behav Res Ther | 2022 |
| 35594047 | Prevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines. | JAMA Netw Open | 2022 |
| 35859209 | Long-Term Adaptation Among Adolescent and Young Adult Children to Familial Cancer Risk. | Pediatrics | 2022 |
| 36108258 | Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer. | JCO Precis Oncol | 2022 |
| 36001346 | Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy. | Cancer Prev Res (Phila) | 2022 |
| 36205748 | Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants. | Genet Med | 2022 |
| 36136322 | Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2. | JAMA Oncol | 2022 |
| 36331239 | Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition. | JCO Precis Oncol | 2022 |
| 35960913 | Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment. | J Clin Oncol | 2022 |
| 36228963 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer. | Ann Oncol | 2022 |
| 36127252 | Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes. | Clin Genitourin Cancer | 2022 |
| 36091175 | An integrated somatic and germline approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genes. | Front Oncol | 2022 |
| 35948032 | Impact of Genetic Counseling on Patient-Reported Electronic Cancer Family History Collection. | J Natl Compr Canc Netw | 2022 |
| 35878831 | Trajectories of positive and negative affect across adolescence: Maternal history of depression and adolescent sex as predictors. | J Affect Disord | 2022 |
| 35220194 | Vulvar Melanoma in association with germline MITF p.E318K variant. | Cancer Genet | 2022 |
| 34906490 | Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort study. | Genet Med | 2022 |
| 34906479 | Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants. | Genet Med | 2022 |
| 34875721 | Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics. | Cancer | 2022 |
| 35174967 | Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition. | Cancer Med | 2022 |
| 35266774 | A positive parenting program to enhance positive affect in children of previously depressed mothers. | J Fam Psychol | 2022 |
| 34863587 | Inherited TP53 Variants and Risk of Prostate Cancer. | Eur Urol | 2022 |